Cilo Cybin Holdings (JSE:CCC) Net Margin % : 0.00% (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cilo Cybin Holdings Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Cilo Cybin Holdings's Net Income for the six months ended in Sep. 2024 was R0.71 Mil. Cilo Cybin Holdings's Revenue for the six months ended in Sep. 2024 was R0.00 Mil. Therefore, Cilo Cybin Holdings's net margin for the quarter that ended in Sep. 2024 was 0.00%.

The historical rank and industry rank for Cilo Cybin Holdings's Net Margin % or its related term are showing as below:

JSE:CCC's Net Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 4.6
* Ranked among companies with meaningful Net Margin % only.

Cilo Cybin Holdings Net Margin % Historical Data

The historical data trend for Cilo Cybin Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cilo Cybin Holdings Net Margin % Chart

Cilo Cybin Holdings Annual Data

Trend

Mar22

Mar23

Net Margin %

Cilo Cybin Holdings Semi-Annual Data
	Mar22	Mar23	Sep23	Sep24
Net Margin %	-	-	-	-

Competitive Comparison of Cilo Cybin Holdings's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cilo Cybin Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cilo Cybin Holdings's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cilo Cybin Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Cilo Cybin Holdings's Net Margin % falls into.

Save Embed

;

Save Embed

;

Cilo Cybin Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Cilo Cybin Holdings's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin	=	Net Income (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	-0.552	/	0
	=	%

Cilo Cybin Holdings's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin	=	Net Income (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	0.709	/	0
	=	%

Cilo Cybin Holdings (JSE:CCC) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Cilo Cybin Holdings Net Margin % Related Terms

Thank you for viewing the detailed overview of Cilo Cybin Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cilo Cybin Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cilo Cybin Holdings Ltd (JSE:CCC) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Sterling Street, The Point Office Park, Unit C1, Samrand, Pretoria, GT, ZAF, 0157

Website

https://www.cilocybin.com

Cilo Cybin Holdings Ltd is a Company whose core focus is on supplying GMP medical cannabis products, including GMP CBD, CBG, CBN isolates and GMP THC and CBD distillates to meet the highest standards of quality, effectiveness, care, and safety. It specializes in supplying medical-grade cannabis flower and final products, using a cold ethanol extraction process with high-quality input materials.

Cilo Cybin Holdings Headlines

No Headlines